137 related articles for article (PubMed ID: 34690219)
1. Prognostic Impact of Pretreatment Serum CYFRA Status in 1047 Patients with Esophageal Squamous Cell Carcinoma Who Underwent Radical Resection: A Japan Esophageal Society Promotion Research.
Ishioka N; Suzuki T; Yajima S; Murakami K; Ohkura Y; Fukuda T; Yagi K; Okamura A; Hoshino I; Kunisaki C; Nakajima Y; Narumiya K; Ogawa R; Shimada H
Ann Thorac Cardiovasc Surg; 2022 Jun; 28(3):163-170. PubMed ID: 34690219
[TBL] [Abstract][Full Text] [Related]
2. Tumor marker index based on preoperative SCC and CYFRA 21-1 is a significant prognostic factor for patients with resectable esophageal squamous cell carcinoma.
Qiao Y; Chen C; Yue J; Yu Z
Cancer Biomark; 2019; 25(3):243-250. PubMed ID: 31282406
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Impact of Serum SCC Antigen in the 566 Upfront Surgery Group of Esophageal Squamous Cell Carcinoma: A Multi-Institutional Study of the Japan Esophageal Society.
Suzuki T; Yajima S; Okamura A; Yoshida N; Taniyama Y; Murakami K; Ohkura Y; Nakajima Y; Yagi K; Fukuda T; Ogawa R; Hoshino I; Kunisaki C; Narumiya K; Tsubosa Y; Yamada K; Shimada H
Ann Thorac Cardiovasc Surg; 2024; 30(1):. PubMed ID: 38583987
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of CYFRA 21-1 in patients with esophageal squamous cell carcinoma.
Shimada H; Nabeya Y; Okazumi S; Matsubara H; Miyazawa Y; Shiratori T; Hayashi H; Gunji Y; Ochiai T
J Am Coll Surg; 2003 Apr; 196(4):573-8. PubMed ID: 12691934
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment serum CYFRA 21-1 level correlates significantly with survival of cervical cancer patients: a multivariate analysis of 506 cases.
Piao X; Kong TW; Chang SJ; Paek J; Chun M; Ryu HS
Gynecol Oncol; 2015 Jul; 138(1):89-93. PubMed ID: 25913134
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of carcinoembryonic antigen in 1822 surgically treated esophageal squamous cell carcinoma: multi-institutional study of the Japan Esophageal Society.
Suzuki T; Yajima S; Okamura A; Yoshida N; Taniyama Y; Murakami K; Ohkura Y; Nakajima Y; Yagi K; Fukuda T; Ogawa R; Hoshino I; Kunisaki C; Narumiya K; Tsubosa Y; Yamada K; Shimada H;
Dis Esophagus; 2022 Dec; 35(12):. PubMed ID: 35661884
[TBL] [Abstract][Full Text] [Related]
7. Clinical impact of preoperative serum p53 antibody titers in 1487 patients with surgically treated esophageal squamous cell carcinoma: a multi-institutional study.
Takashi S; Satoshi Y; Akihiko O; Naoya Y; Yusuke T; Kentaro M; Yu O; Yasuaki N; Koichi Y; Takashi F; Ryo O; Isamu H; Chikara K; Kosuke N; Yasuhiro T; Kazuhiko Y; Hideaki S
Esophagus; 2021 Jan; 18(1):65-71. PubMed ID: 32715348
[TBL] [Abstract][Full Text] [Related]
8. Correlation between Serum SCCA and CYFRA 2 1-1, Tissue Ki-67, and Clinicopathological Factors in Patients with Esophageal Squamous Cell Carcinoma.
Sunpaweravong S; Puttawibul P; Sunpaweravong P; Nitiruangjaras A; Boonyaphiphat P; Kemapanmanus M
J Med Assoc Thai; 2016 Mar; 99(3):331-7. PubMed ID: 27276745
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of serum CYFRA 21-1 1 in patients with anal canal squamous cell carcinoma treated with radio(chemo)therapy.
Gauthé M; Richard-Molard M; Rigault E; Buecher B; Mariani P; Bellet D; Cacheux W; Lièvre A
BMC Cancer; 2018 Apr; 18(1):417. PubMed ID: 29653564
[TBL] [Abstract][Full Text] [Related]
10. High preoperative and postoperative levels of carcinoembryonic antigen and CYFRA 21-1 indicate poor prognosis in patients with pathological Stage I nonsmall cell lung cancer.
Duan X; Cui Y; Li H; Shi G; Wu B; Liu M; Chang D; Wang T; Kong Y
Indian J Cancer; 2015 Dec; 52 Suppl 3():E158-63. PubMed ID: 27453414
[TBL] [Abstract][Full Text] [Related]
11. Predictive significance of CYFRA21-1, squamous cell carcinoma antigen and carcinoembryonic antigen for lymph node metastasis in patients with esophageal squamous cancer.
Mei X; Zhu X; Zuo L; Wu H; Guo M; Liu C
Int J Biol Markers; 2019 Jun; 34(2):200-204. PubMed ID: 31088185
[TBL] [Abstract][Full Text] [Related]
12. Cytokeratin 19 fragment antigen 21-1 as an independent predictor for definitive chemoradiotherapy sensitivity in esophageal squamous cell carcinoma.
Yan HJ; Wang RB; Zhu KL; Jiang SM; Zhao W; Xu XQ; Feng R
Chin Med J (Engl); 2012 Apr; 125(8):1410-5. PubMed ID: 22613644
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of serum C-reactive protein (CRP) and cytokeratin 19 fragments (Cyfra 21-1) but not carcinoembryonic antigen (CEA) in surgically treated patients with non-small cell lung cancer.
Szturmowicz M; Rudziński P; Kacprzak A; Langfort R; Bestry I; Broniarek-Samson B; Orłowski T
Pneumonol Alergol Pol; 2014; 82(5):422-9. PubMed ID: 25133810
[TBL] [Abstract][Full Text] [Related]
14. Elevated serum levels of TPS and CYFRA 21-1 predict poor prognosis in advanced non-small-cell lung cancer patients treated with gefitinib.
Chen F; Luo X; Zhang J; Lu Y; Luo R
Med Oncol; 2010 Sep; 27(3):950-7. PubMed ID: 19830603
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment Serum Levels of Soluble Cytokeratin Fragments (Cyfra 21-1, TPS, MonoTotal) in Relation to Clinical and Pathobiological Aspects of Head and Neck Squamous Cell Carcinomas.
Kalfert D; Ludvik J; Kucera R; Topolcan O; Celakovsky P; Pesta M; Kholova I; Plzak J; Ludvikova M
Anticancer Res; 2019 Sep; 39(9):5171-5177. PubMed ID: 31519630
[TBL] [Abstract][Full Text] [Related]
16. Analysis of serum CYFRA 21-1 concentrations in patients with esophageal cancer.
Brockmann JG; St Nottberg H; Glodny B; Sprakel B; Senninger N
Anticancer Res; 2000; 20(6D):4899-904. PubMed ID: 11332443
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of the pretreatment serum level of cytokeratin fraction 21-1 in undifferentiated nasopharyngeal carcinoma: a study of 332 cases.
Wei Z; Zeng X; Xu J; Duan X; Yang J; Xie Y
Head Neck; 2014 Jan; 36(1):71-6. PubMed ID: 23728904
[TBL] [Abstract][Full Text] [Related]
18. Clinical usefulness of CYFRA 21-1 for esophageal squamous cell carcinoma in radiation therapy.
Wakatsuki M; Suzuki Y; Nakamoto S; Ohno T; Ishikawa H; Kiyohara H; Kiyozuka M; Shirai K; Nakayama Y; Nakano T
J Gastroenterol Hepatol; 2007 May; 22(5):715-9. PubMed ID: 17444861
[TBL] [Abstract][Full Text] [Related]
19. CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patients.
Pujol JL; Molinier O; Ebert W; Daurès JP; Barlesi F; Buccheri G; Paesmans M; Quoix E; Moro-Sibilot D; Szturmowicz M; Bréchot JM; Muley T; Grenier J
Br J Cancer; 2004 Jun; 90(11):2097-105. PubMed ID: 15150567
[TBL] [Abstract][Full Text] [Related]
20. Preoperative serum CYFRA 21-1 level as a prognostic factor in surgically treated adenocarcinoma of lung.
Park SY; Lee JG; Kim J; Park Y; Lee SK; Bae MK; Lee CY; Kim DJ; Chung KY
Lung Cancer; 2013 Feb; 79(2):156-60. PubMed ID: 23206831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]